CLINICAL EFFICACY AND ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS AND ORAL ENCAINIDE IN PATIENTS WITH ACCESSORY ATRIOVENTRICULAR PATHWAYS AND SUPRAVENTRICULAR ARRHYTHMIAS

被引:33
作者
ABDOLLAH, H [1 ]
BRUGADA, P [1 ]
GREEN, M [1 ]
WEHR, M [1 ]
WELLENS, HJJ [1 ]
PAULUSSEN, G [1 ]
机构
[1] UNIV LIMBURG,ANNADAL HOSP,DEPT CARDIOL,6201 BX MAASTRICHT,NETHERLANDS
关键词
D O I
10.1016/0002-9149(84)90245-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:544 / 549
页数:6
相关论文
共 11 条
[1]   ELECTROPHYSIOLOGY OF ORAL ENCAINIDE [J].
JACKMAN, WM ;
ZIPES, DP ;
NACCARELLI, GV ;
RINKENBERGER, RL ;
HEGER, JJ ;
PRYSTOWSKY, EN .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (05) :1270-1278
[2]   METABOLITE CUMULATION DURING LONG-TERM ORAL ENCAINIDE ADMINISTRATION [J].
KATES, RE ;
HARRISON, DC ;
WINKLE, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :427-432
[3]   CLINICAL-EXPERIENCE OF ENCAINIDE (MJ-9067) - NEW ANTI-ARRHYTHMIC DRUG [J].
KESTELOOT, H ;
STROOBANDT, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) :323-326
[4]   ANTI-ARRHYTHMIC EFFICACY OF ENCAINIDE IN PATIENTS WITH REFRACTORY RECURRENT VENTRICULAR-TACHYCARDIA [J].
MASON, JW ;
PETERS, FA .
CIRCULATION, 1981, 63 (03) :670-675
[5]   CLINICAL EFFICACY AND ELECTROPHYSIOLOGIC EFFECTS OF ENCAINIDE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME [J].
PRYSTOWSKY, EN ;
KLEIN, GJ ;
RINKENBERGER, RL ;
HEGER, JJ ;
NACCARELLI, GV ;
ZIPES, DP .
CIRCULATION, 1984, 69 (02) :278-287
[6]   TOTAL SUPPRESSION OF VENTRICULAR ARRHYTHMIAS BY ENCAINIDE - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CHARACTERISTICS [J].
RODEN, DM ;
REELE, SB ;
HIGGINS, SB ;
MAYOL, RF ;
GAMMANS, RE ;
OATES, JA ;
WOOSLEY, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (16) :877-882
[7]   CLINICAL ELECTROPHYSIOLOGIC EFFECTS OF ENCAINIDE, A NEWLY DEVELOPED ANTI-ARRHYTHMIC AGENT [J].
SAMI, M ;
MASON, JW ;
PETERS, F ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (03) :526-532
[8]   ANTI-ARRHYTHMIC EFFICACY OF ENCAINIDE AND QUINIDINE - VALIDATION OF A MODEL FOR DRUG ASSESSMENT [J].
SAMI, M ;
HARRISON, DC ;
KRAEMER, H ;
HOUSTON, N ;
SHIMASAKI, C ;
DEBUSK, RF .
AMERICAN JOURNAL OF CARDIOLOGY, 1981, 48 (01) :147-156
[9]   EFFECT OF DRUGS IN THE WOLFF-PARKINSON-WHITE SYNDROME - IMPORTANCE OF INITIAL LENGTH OF EFFECTIVE REFRACTORY PERIOD OF THE ACCESSORY PATHWAY [J].
WELLENS, HJJ ;
BAR, FW ;
DASSEN, WRM ;
BRUGADA, P ;
VANAGT, EJ ;
FARRE, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (04) :665-669